NO924929D0 - Farmasoeytisk aktive benzoquinazolinforbindelser - Google Patents

Farmasoeytisk aktive benzoquinazolinforbindelser

Info

Publication number
NO924929D0
NO924929D0 NO924929A NO924929A NO924929D0 NO 924929 D0 NO924929 D0 NO 924929D0 NO 924929 A NO924929 A NO 924929A NO 924929 A NO924929 A NO 924929A NO 924929 D0 NO924929 D0 NO 924929D0
Authority
NO
Norway
Prior art keywords
pharmasoeytic
active
benzoquinazoline
compounds
benzoquinazoline compounds
Prior art date
Application number
NO924929A
Other languages
English (en)
Norwegian (no)
Other versions
NO924929L (no
Inventor
William Pendergast
Scott Howard Dickerson
Julius Vass Johnson
Robert Ferone
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO924929L publication Critical patent/NO924929L/no
Publication of NO924929D0 publication Critical patent/NO924929D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO924929A 1990-06-19 1992-12-18 Farmasoeytisk aktive benzoquinazolinforbindelser NO924929D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909013615A GB9013615D0 (en) 1990-06-19 1990-06-19 Pharmaceutical compounds
PCT/GB1991/000977 WO1991019700A1 (en) 1990-06-19 1991-06-18 Pharmaceutically active benzoquinazoline compounds

Publications (2)

Publication Number Publication Date
NO924929L NO924929L (no) 1992-12-18
NO924929D0 true NO924929D0 (no) 1992-12-18

Family

ID=10677828

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924929A NO924929D0 (no) 1990-06-19 1992-12-18 Farmasoeytisk aktive benzoquinazolinforbindelser

Country Status (26)

Country Link
US (4) US6090941A (de)
EP (2) EP0535034B1 (de)
JP (1) JP2966929B2 (de)
KR (1) KR0183042B1 (de)
CN (1) CN1049215C (de)
AP (1) AP218A (de)
AT (2) ATE222243T1 (de)
AU (1) AU639815B2 (de)
CA (1) CA2085589C (de)
CS (1) CS186391A3 (de)
DE (2) DE69133088T2 (de)
DK (2) DK1199307T3 (de)
ES (2) ES2211851T3 (de)
FI (1) FI925778A7 (de)
GB (1) GB9013615D0 (de)
HU (2) HUT62273A (de)
IE (1) IE912073A1 (de)
IL (1) IL98542A (de)
MC (1) MC2290A1 (de)
MY (1) MY107001A (de)
NO (1) NO924929D0 (de)
NZ (1) NZ238582A (de)
PL (1) PL169927B1 (de)
PT (1) PT98021B (de)
WO (1) WO1991019700A1 (de)
ZA (1) ZA914676B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
WO2000055166A1 (en) 1999-03-16 2000-09-21 Regents Of The University Of California Glycosylated polyamines
US6531454B1 (en) 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
EP1286661A2 (de) * 2000-06-09 2003-03-05 OSI Pharmaceuticals, Inc. Liposomale benzochinazolin thymidylat-synthaseinhibitor formulierungen
CN1578781A (zh) * 2001-09-26 2005-02-09 拜尔药品公司 用作抗糖尿病药物的1,8-萘啶衍生物
CN100434425C (zh) * 2005-03-09 2008-11-19 首都师范大学 4-喹唑啉酮衍生物及其在抗肿瘤药物中的应用
EP1754484A1 (de) 2005-08-17 2007-02-21 Dan Stoicescu Kondensierte Pyrimidinderivative als Inhibitoren der Folsäure-abhängiger Enzyme
CA2631704A1 (en) 2005-12-05 2007-06-14 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
GB0525069D0 (en) * 2005-12-08 2006-01-18 Novartis Ag Organic compounds
EP2079739A2 (de) 2006-10-04 2009-07-22 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-onderivate als kalziumrezeptorantagonisten
EP1958632A1 (de) 2007-02-14 2008-08-20 Dan Stoicescu Kondensierte Pyrimidinderivaten zur Behandlung von Entzündungserkrankungen und Autoimmunerkrankungen
JP2010528122A (ja) * 2007-05-09 2010-08-19 日東電工株式会社 白金薬剤と結合されたポリマー
CA2683590A1 (en) * 2007-05-09 2008-11-20 Nitto Denko Corporation Compositions that include a hydrophobic compound and a polyamino acid conjugate
CN101707869A (zh) * 2007-05-09 2010-05-12 日东电工株式会社 具有多种药物的聚谷氨酸盐结合物和聚谷氨酸盐-氨基酸结合物
US8517760B2 (en) 2007-08-20 2013-08-27 Ford Global Technologies, Llc Cord wrap and power plug receptacle arrangement for inflator
US8146622B2 (en) 2007-08-20 2012-04-03 Ford Global Technologies, Llc Switch and hose-valve connection arrangement for vehicle temporary mobility kit
US8501242B2 (en) 2009-05-29 2013-08-06 University Of Florida Research Foundation Methods and compositions for treating neoplasia
CN101580501B (zh) 2009-06-01 2011-03-09 南京卡文迪许生物工程技术有限公司 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体
WO2011078226A1 (ja) * 2009-12-22 2011-06-30 協和発酵キリン株式会社 三環系化合物
AU2021356130A1 (en) 2020-10-08 2023-05-18 Redona Therapeutics, Inc. Benzo[h]quinazolin-4-amine and thieno[3,2-h]quinazolin-4-amine derivatives for the treatment of cancer
CN116547280A (zh) * 2020-10-08 2023-08-04 雷多纳治疗公司 用于治疗癌症的苯并[h]喹唑啉-4-胺和噻吩并[3,2-h]喹唑啉-4-胺衍生物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UST862021I4 (en) * 1969-01-27 1969-05-27 Defensive publication
DE2202847A1 (de) * 1971-02-05 1972-08-17 Apaw Sa Speiseeismaschine,insbesondere fuer Familiengebrauch,Kleinbetriebe od.dgl.
DE3069468D1 (en) * 1979-12-19 1984-11-22 Nat Res Dev Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US4603186A (en) 1985-10-21 1986-07-29 The Standard Oil Company Tetrapolymers containing indene
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
US4902624A (en) * 1987-11-23 1990-02-20 Eastman Kodak Company Temperature cycling cuvette
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US5405851A (en) * 1990-06-19 1995-04-11 Burroughs Wellcome Co. Pharmaceutical compounds

Also Published As

Publication number Publication date
CA2085589A1 (en) 1991-12-20
ES2211851T3 (es) 2004-07-16
JPH05507704A (ja) 1993-11-04
KR930701415A (ko) 1993-06-11
IE912073A1 (en) 1992-01-01
JP2966929B2 (ja) 1999-10-25
IL98542A (en) 1995-05-26
DE69133088D1 (de) 2002-09-19
US5661155A (en) 1997-08-26
US5663337A (en) 1997-09-02
AP218A (en) 1992-09-27
AP9100283A0 (en) 1991-07-31
ATE260262T1 (de) 2004-03-15
CN1049215C (zh) 2000-02-09
WO1991019700A1 (en) 1991-12-26
ZA914676B (en) 1993-02-24
MC2290A1 (fr) 1993-07-14
PT98021B (pt) 1998-11-30
US6090941A (en) 2000-07-18
DK0535034T3 (da) 2002-12-09
IL98542A0 (en) 1992-07-15
AU639815B2 (en) 1993-08-05
NO924929L (no) 1992-12-18
KR0183042B1 (ko) 1999-05-01
CN1058208A (zh) 1992-01-29
CA2085589C (en) 2001-12-18
GB9013615D0 (en) 1990-08-08
HU9204011D0 (en) 1993-03-29
US6306865B1 (en) 2001-10-23
PL169927B1 (pl) 1996-09-30
PT98021A (pt) 1992-04-30
EP1199307A1 (de) 2002-04-24
ES2178632T3 (es) 2003-01-01
HU211265A9 (en) 1995-11-28
NZ238582A (en) 1993-12-23
EP0535034A1 (de) 1993-04-07
MY107001A (en) 1995-08-30
EP1199307B1 (de) 2004-02-25
FI925778A0 (fi) 1992-12-18
DE69133371D1 (de) 2004-04-01
FI925778A7 (fi) 1992-12-18
DK1199307T3 (da) 2004-06-14
HUT62273A (en) 1993-04-28
CS186391A3 (en) 1992-04-15
DE69133371T2 (de) 2005-01-27
AU8094391A (en) 1992-01-07
EP0535034B1 (de) 2002-08-14
DE69133088T2 (de) 2003-03-20
ATE222243T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
MX9100513A (es) Compuestos
BR1100956A (pt) Composto
DE69123611D1 (de) Aktiver Filter
FI925228L (fi) Oekad staerkelsehalt i vaexter
ATA150090A (de) Hoergeraet
NO924929D0 (no) Farmasoeytisk aktive benzoquinazolinforbindelser
MX9100517A (es) Compuestos
FI931365L (fi) Polyhydroxifettsyraamider i polykarboxylatbaserade tvaettmedel
FI932771L (fi) Maetningsfoerfarande foer hartspartiklar i pappersmassa
MX9101501A (es) Compuestos novedosos
FI925980A7 (fi) Bisheterocykliska foereningar
FI930797L (fi) Insektbestaendig formkropp anvaendbar i lantbruksbyggnader
ATA210290A (de) Lotpille
FI924321L (fi) Besprutningsbara kompositioner foer anvaendning i jordbruk
DK106991A (da) Dichloranilinforbindelser
ATA200090A (de) Pianino
FI924296L (fi) Rengoeringsprodukter i vaetskeform
FI932766A7 (fi) Torjunta-aineyhdisteitä
ATA209290A (de) Diaraehmchen
ATA237490A (de) Rinnenstein
IT9020674A1 (it) Composti ammelinici
MX174411B (es) Compuestos
BR1101075A (pt) Compostos azasteróides
SE9201338D0 (sv) New active compounds
SE9202553D0 (sv) New active compounds ii